Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,004 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Taming the SARS-CoV-2-mediated proinflammatory response with BromAc®.
Ferreira GM, Clarindo FA, Ribeiro ÁL, Gomes-de-Pontes L, de Carvalho LD, Martins-Filho OA, da Fonseca FG, Teixeira MM, Sabino AP, Eapen MS, Morris DL, Valle SJ, Coelho-Dos-Reis JGA. Ferreira GM, et al. Among authors: teixeira mm. Front Immunol. 2023 Dec 13;14:1308477. doi: 10.3389/fimmu.2023.1308477. eCollection 2023. Front Immunol. 2023. PMID: 38193087 Free PMC article.
Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis.
Marín-Prida J, Pavón-Fuentes N, Lagumersindez-Denis N, Camacho-Rodríguez H, García-Soca AM, Sarduy-Chávez RC, Vieira ÉLM, Carvalho-Tavares J, Falcón-Cama V, Fernández-Massó JR, Hernández-González I, Martínez-Donato G, Guillén-Nieto G, Pentón-Arias E, Teixeira MM, Pentón-Rol G. Marín-Prida J, et al. Among authors: teixeira mm. Front Immunol. 2022 Nov 3;13:1036200. doi: 10.3389/fimmu.2022.1036200. eCollection 2022. Front Immunol. 2022. PMID: 36405721 Free PMC article.
The effects of Phycocyanobilin on experimental arthritis involve the reduction in nociception and synovial neutrophil infiltration, inhibition of cytokine production, and modulation of the neuronal proteome.
Marín-Prida J, Rodríguez-Ulloa A, Besada V, Llopiz-Arzuaga A, Batista NV, Hernández-González I, Pavón-Fuentes N, Marciano Vieira ÉL, Falcón-Cama V, Acosta EF, Martínez-Donato G, Cervantes-Llanos M, Lingfeng D, González LJ, Fernández-Massó JR, Guillén-Nieto G, Pentón-Arias E, Amaral FA, Teixeira MM, Pentón-Rol G. Marín-Prida J, et al. Among authors: teixeira mm. Front Immunol. 2023 Oct 23;14:1227268. doi: 10.3389/fimmu.2023.1227268. eCollection 2023. Front Immunol. 2023. PMID: 37936684 Free PMC article.
The glycosaminoglycan-binding chemokine fragment CXCL9(74-103) reduces inflammation and tissue damage in mouse models of coronavirus infection.
Oliveira VLS, Queiroz-Junior CM, Hoorelbeke D, Santos FRDS, Chaves IM, Teixeira MM, Russo RC, Proost P, Costa VV, Struyf S, Amaral FA. Oliveira VLS, et al. Among authors: teixeira mm. Front Immunol. 2024 Apr 15;15:1378591. doi: 10.3389/fimmu.2024.1378591. eCollection 2024. Front Immunol. 2024. PMID: 38686377 Free PMC article.
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV).
Wongnak P, Schilling WHK, Jittamala P, Boyd S, Luvira V, Siripoon T, Ngamprasertchai T, Batty EM, Singh S, Kouhathong J, Pagornrat W, Khanthagan P, Hanboonkunupakarn B, Poovorawan K, Mayxay M, Chotivanich K, Imwong M, Pukrittayakamee S, Ashley EA, Dondorp AM, Day NPJ, Teixeira MM, Piyaphanee W, Phumratanaprapin W, White NJ, Watson JA; PLATCOV Collaborative Group. Wongnak P, et al. Among authors: teixeira mm. Lancet Infect Dis. 2024 Apr 24:S1473-3099(24)00183-X. doi: 10.1016/S1473-3099(24)00183-X. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38677300 Free article.
A single dose of angiotensin-(1-7) resolves eosinophilic inflammation and protects the lungs from a secondary inflammatory challenge.
Magalhaes GS, Gregorio JF, Beltrami VA, Felix FB, Oliveira-Campos L, Bonilha CS, Righetti RF, Tibério IFLC, De Sousa FB, Rezende BM, Teixeira-Carvalho A, Santos RA, Campagnole-Santos MJ, Rodrigues-Machado MDG, Teixeira MM, Pinho V. Magalhaes GS, et al. Among authors: teixeira mm. Inflamm Res. 2024 Apr 24. doi: 10.1007/s00011-024-01880-x. Online ahead of print. Inflamm Res. 2024. PMID: 38656426
Epidemiological, clinical, and genomic landscape of coccidioidomycosis in northeastern Brazil.
Eulálio KD, Kollath DR, Martins LMS, Filho AD, Cavalcanti MDAS, Moreira LM, Tenório BG, Alves LGB, Yamauchi D, Barrozo LV, Thompson Iii GR, Nacher M, Stajich JE, Benard G, Bagagli E, Felipe MSS, Barker BM, Trilles L, Teixeira MM. Eulálio KD, et al. Among authors: teixeira mm. Nat Commun. 2024 Apr 12;15(1):3190. doi: 10.1038/s41467-024-47388-0. Nat Commun. 2024. PMID: 38609393 Free PMC article.
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review.
Papapetropoulos A, Topouzis S, Alexander SPH, Cortese-Krott M, Kendall DA, Martemyanov KA, Mauro C, Nagercoil N, Panettieri RA Jr, Patel HH, Schulz R, Stefanska B, Stephens GJ, Teixeira MM, Vergnolle N, Wang X, Ferdinandy P. Papapetropoulos A, et al. Among authors: teixeira mm. Br J Pharmacol. 2024 Jun;181(11):1553-1575. doi: 10.1111/bph.16337. Epub 2024 Mar 22. Br J Pharmacol. 2024. PMID: 38519837 Review.
1,004 results